BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 8038476)

  • 1. Cisapride: a gastrointestinal prokinetic drug.
    Barone JA; Jessen LM; Colaizzi JL; Bierman RH
    Ann Pharmacother; 1994 Apr; 28(4):488-500. PubMed ID: 8038476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders.
    Wiseman LR; Faulds D
    Drugs; 1994 Jan; 47(1):116-52. PubMed ID: 7510617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domperidone: a peripherally acting dopamine2-receptor antagonist.
    Barone JA
    Ann Pharmacother; 1999 Apr; 33(4):429-40. PubMed ID: 10332535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders.
    McCallum RW; Prakash C; Campoli-Richards DM; Goa KL
    Drugs; 1988 Dec; 36(6):652-81. PubMed ID: 3065057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A risk-benefit assessment of cisapride in the treatment of gastrointestinal disorders.
    Tack J; Coremans G; Janssens J
    Drug Saf; 1995 Jun; 12(6):384-92. PubMed ID: 8527013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cisapride: pharmacology, current therapeutic results and future prospects].
    Fraitag B; Cloarec D; Galmiche JP
    Gastroenterol Clin Biol; 1989 Mar; 13(3):265-76. PubMed ID: 2659417
    [No Abstract]   [Full Text] [Related]  

  • 7. Prokinetic therapy for gastroesophageal reflux disease.
    Robinson M
    Am Fam Physician; 1995 Sep; 52(3):957-62, 965-6. PubMed ID: 7653432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisapride.
    Washabau RJ; Hall JA
    J Am Vet Med Assoc; 1995 Nov; 207(10):1285-8. PubMed ID: 7591920
    [No Abstract]   [Full Text] [Related]  

  • 9. Cisapride, metoclopramide, and ranitidine in the treatment of severe nonulcer dyspepsia.
    Archimandritis A; Tzivras M; Fertakis A; Emmanuel A; Laoudi F; Kalantzis N; Anthopoulou H; Michailidis D
    Clin Ther; 1992; 14(4):553-61. PubMed ID: 1525789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacologic and clinical differentiation of prokinetic drugs].
    May B; Greving I
    Leber Magen Darm; 1996 Jul; 26(4):193-8. PubMed ID: 8965601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisapride.
    Molinari F; Farrington E
    Pediatr Nurs; 1994; 20(2):202-3. PubMed ID: 8159508
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of chronic-obstructive upper abdominal complaints. Outlook. Further hypothetical indications].
    Fortschr Med Suppl; 1990; 87():15-6. PubMed ID: 2190899
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of cisapride on symptoms and healing of gastro-oesophageal reflux disease: a review.
    Richter JE
    Scand J Gastroenterol Suppl; 1989; 165():19-27; discussion 27-8. PubMed ID: 2690321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prokinetic agents: a key in the future of gastroenterology.
    Reynolds JC
    Gastroenterol Clin North Am; 1989 Jun; 18(2):437-57. PubMed ID: 2668178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisapride.
    Mangal N; Singh J; Sharma U; Patni T
    Indian Pediatr; 1995 Oct; 32(10):1124-6. PubMed ID: 8984056
    [No Abstract]   [Full Text] [Related]  

  • 16. Cisapride compared with ranitidine in the treatment of functional dyspepsia.
    Carvalhinhos A; Fidalgo P; Freire A; Matos L
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):411-7. PubMed ID: 7614103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisapride--more selective than metoclopramide.
    Drug Ther Bull; 1990 Nov; 28(23):89-90. PubMed ID: 2131232
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of cisapride on parameters of oesophageal motility and on the prolonged intraoesophageal pH test in infants with gastro-oesophageal reflux disease.
    Cucchiara S; Staiano A; Boccieri A; De Stefano M; Capozzi C; Manzi G; Camerlingo F; Paone FM
    Gut; 1990 Jan; 31(1):21-5. PubMed ID: 2180792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisapride for gastroesophageal reflux disease: a placebo-controlled, double-blind study.
    Richter JE; Long JF
    Am J Gastroenterol; 1995 Mar; 90(3):423-30. PubMed ID: 7872282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Canadian Cisapride Nud Study Group.
    Champion MC; MacCannell KL; Thomson AB; Tanton R; Eberhard S; Sullivan SN; Archambault A
    Can J Gastroenterol; 1997 Mar; 11(2):127-34. PubMed ID: 9113812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.